CONSOL Remains Top Pick in Coal Space and 4 Stock Analyses to Know Now
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Current Price: $177.93
RBC Capital thinks that Regeneron is at an attractive entry point due to its belief that the market is undervaluing the near-term market opportunity of Regeneron’s Eylea treatment along with its broader pipeline. The firm recommends purchasing the stock on pullbacks and it keeps its Outperform rating on the stock.
Angie’s List Inc (NASDAQ:ANGI): Current Price: $13.31
Oppenheimer predicts that Angie’s List will see benefits as a result of a stronger housing market, improving margins, and a low valuation versus its peers. The firm keeps its Outperform rating and a $15 price target on the stock.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
Move, Inc. (NASDAQ:MOVE): Current Price: $9.67
Oppenheimer is convinced that Move is in the position for strong revenue growth during 2013 and it continues to be an attractive play on the U.S. housing recovery. The firm believes that the stock’s valuation as highly compelling compared to its competitors and it keeps its Outperform rating on the stock.
Cisco Systems, Inc. (NASDAQ:CSCO):Current Price: $21.27
According to Stifel Nicolaus, Cisco’s January quarter results will be slightly better than expected as a result of improved U.S. trends. The firm thinks that data center switching is shown good performance and it believes that the tone of the conference call will be positive. The firm keeps its Buy rating on the stock.
CONSOL Energy Inc. (NYSE:CNX): Current Price: $32.33
Brean Capital has stated that CONSOL Energy has intentions to monetize, particularly assets likely qualifying for Master Limited Partnership status. This move would add meaningful value for shareholders and CONSOL continues to be a top pick in the coal space. The firm gives the shares a Buy rating and a $44 price target.
Don’t Miss: Is Green Mountain a Bargain Here?